The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
ALEXANDRIA, Va. — New recommendations on the use of chemotherapy to treat patients with stage 4 non-small cell lung cancer (NSCLC) were issued today by the American Society of Clinical Oncology (ASCO).
ALEXANDRIA, Va. - ASCO is pleased that the FDA has issued new rules that strike a balance between meeting the immediate needs of seriously ill cancer patients today, while safeguarding the clinical trials system so it can develop new drugs to treat cancer patients in the future.
ALEXANDRIA, Va - A study conducted by the American Society of Clinical Oncology (ASCO) finds that different interpretations of the U.S. Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule can result in significant delays or abandonment of important clinical cancer research projects. The study also outlines measures that research sites can undertake to resolve these differences and speed the pace of research.
ALEXANDRIA, Va.—Today, the application period opens for the largest grant in the history of The ASCO Cancer Foundation®. The Improving Cancer Care Grant, funded by Susan G. Komen for the Cure®, will fund up to three research grants, each totaling $1.35 million, for research studies that implement and evaluate new ways to solve major problems in quality of, access to, and delivery of cancer care.
ALEXANDRIA, Va. —The American Society of Clinical Oncology (ASCO) has commissioned a new study, funded by Susan G. Komen for the Cure®, to find out how non-physician practitioners, such as nurse practitioners and physician assistants, can provide vital services to cancer patients as part of continued efforts to address projected future oncology workforce shortages.
ALEXANDRIA, Va. - President Obama’s signature on the Family Smoking Prevention and Tobacco Control Act marks a new era in which the federal government now has sweeping regulatory authority over how tobacco products are manufactured and marketed in the United States. Food and Drug Administration (FDA) regulation of tobacco products should have a significant impact on reducing the widespread death and disease caused by tobacco use.
Orlando, Fla. – The American Society of Clinical Oncology (ASCO) today announced the Quality Oncology Practice Initiative (QOPI®) Certification Program, a new program to certify oncology practices that achieve rigorous standards for high-quality cancer care.
Alexandria, VA - “The continued decline in cancer death rates is good news for cancer patients – and shows that researchers’ efforts to find better treatments are paying off."
Alexandria, Va. — A newly updated guideline from the American Society of Clinical Oncology (ASCO) states that post-menopausal women who are at increased risk for breast cancer could benefit from taking either tamoxifen or raloxifene to reduce their risk of developing the disease.
